BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18954305)

  • 1. Structural basis and specificity of human otubain 1-mediated deubiquitination.
    Edelmann MJ; Iphöfer A; Akutsu M; Altun M; di Gleria K; Kramer HB; Fiebiger E; Dhe-Paganon S; Kessler BM
    Biochem J; 2009 Mar; 418(2):379-90. PubMed ID: 18954305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of NEDD8 ubiquitin discrimination by the deNEDDylating enzyme NEDP1.
    Shen LN; Liu H; Dong C; Xirodimas D; Naismith JH; Hay RT
    EMBO J; 2005 Apr; 24(7):1341-51. PubMed ID: 15775960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging-Based Screening of Deubiquitinating Proteases Identifies Otubain-1 as a Stabilizer of c-MYC.
    Moree SE; Maneix L; Iakova P; Stossi F; Sahin E; Catic A
    Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Deubiquitylase Otub1 Regulates the Chemotactic Response of Splenic B Cells by Modulating the Stability of the γ-Subunit Gng2.
    Luo VM; Shen C; Worme S; Bhagrath A; Simo-Cheyou E; Findlay S; Hébert S; Wai Lam Poon W; Aryanpour Z; Zhang T; Zahedi RP; Boulais J; Buchwald ZS; Borchers CH; Côté JF; Kleinman CL; Mandl JN; Orthwein A
    Mol Cell Biol; 2024 Jan; 44(1):1-16. PubMed ID: 38270191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of OTUB1-mediated inhibition of ubiquitination.
    Wiener R; Zhang X; Wang T; Wolberger C
    Nature; 2012 Feb; 483(7391):618-22. PubMed ID: 22367539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1.
    Nakada S; Tai I; Panier S; Al-Hakim A; Iemura S; Juang YC; O'Donnell L; Kumakubo A; Munro M; Sicheri F; Gingras AC; Natsume T; Suda T; Durocher D
    Nature; 2010 Aug; 466(7309):941-6. PubMed ID: 20725033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2 ubiquitin-conjugating enzymes regulate the deubiquitinating activity of OTUB1.
    Wiener R; DiBello AT; Lombardi PM; Guzzo CM; Zhang X; Matunis MJ; Wolberger C
    Nat Struct Mol Biol; 2013 Sep; 20(9):1033-9. PubMed ID: 23955022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OTUB1 co-opts Lys48-linked ubiquitin recognition to suppress E2 enzyme function.
    Juang YC; Landry MC; Sanches M; Vittal V; Leung CC; Ceccarelli DF; Mateo AR; Pruneda JN; Mao DY; Szilard RK; Orlicky S; Munro M; Brzovic PS; Klevit RE; Sicheri F; Durocher D
    Mol Cell; 2012 Feb; 45(3):384-97. PubMed ID: 22325355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaking the chains: structure and function of the deubiquitinases.
    Komander D; Clague MJ; Urbé S
    Nat Rev Mol Cell Biol; 2009 Aug; 10(8):550-63. PubMed ID: 19626045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human otubain2-ubiquitin structure provides insights into the cleavage specificity of poly-ubiquitin-linkages.
    Altun M; Walter TS; Kramer HB; Herr P; Iphöfer A; Boström J; David Y; Komsany A; Ternette N; Navon A; Stuart DI; Ren J; Kessler BM
    PLoS One; 2015; 10(1):e0115344. PubMed ID: 25590432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OTUB1 enhances TGFβ signalling by inhibiting the ubiquitylation and degradation of active SMAD2/3.
    Herhaus L; Al-Salihi M; Macartney T; Weidlich S; Sapkota GP
    Nat Commun; 2013; 4():2519. PubMed ID: 24071738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoubiquitination is critical for ovarian tumor domain-containing ubiquitin aldehyde binding protein 1 (Otub1) to suppress UbcH5 enzyme and stabilize p53 protein.
    Li Y; Sun XX; Elferich J; Shinde U; David LL; Dai MS
    J Biol Chem; 2014 Feb; 289(8):5097-108. PubMed ID: 24403071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis.
    Mevissen TE; Hospenthal MK; Geurink PP; Elliott PR; Akutsu M; Arnaudo N; Ekkebus R; Kulathu Y; Wauer T; El Oualid F; Freund SM; Ovaa H; Komander D
    Cell; 2013 Jul; 154(1):169-84. PubMed ID: 23827681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance.
    Karunarathna U; Kongsema M; Zona S; Gong C; Cabrera E; Gomes AR; Man EP; Khongkow P; Tsang JW; Khoo US; Medema RH; Freire R; Lam EW
    Oncogene; 2016 Mar; 35(11):1433-44. PubMed ID: 26148240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for bidentate substrate binding as the basis for the K48 linkage specificity of otubain 1.
    Wang T; Yin L; Cooper EM; Lai MY; Dickey S; Pickart CM; Fushman D; Wilkinson KD; Cohen RE; Wolberger C
    J Mol Biol; 2009 Mar; 386(4):1011-23. PubMed ID: 19211026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OTUB1-catalyzed deubiquitination of FOXM1 facilitates tumor progression and predicts a poor prognosis in ovarian cancer.
    Wang Y; Zhou X; Xu M; Weng W; Zhang Q; Yang Y; Wei P; Du X
    Oncotarget; 2016 Jun; 7(24):36681-36697. PubMed ID: 27167337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OTU Domain-containing ubiquitin aldehyde-binding protein 1 (OTUB1) deubiquitinates estrogen receptor (ER) alpha and affects ERalpha transcriptional activity.
    Stanišić V; Malovannaya A; Qin J; Lonard DM; O'Malley BW
    J Biol Chem; 2009 Jun; 284(24):16135-16145. PubMed ID: 19383985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OTUB1 modulates c-IAP1 stability to regulate signalling pathways.
    Goncharov T; Niessen K; de Almagro MC; Izrael-Tomasevic A; Fedorova AV; Varfolomeev E; Arnott D; Deshayes K; Kirkpatrick DS; Vucic D
    EMBO J; 2013 Apr; 32(8):1103-14. PubMed ID: 23524849
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.